Which Test is Best for Pain in the Chest?

Chest pain represents a ubiquitous clinical challenge across diverse medical environments, necessitating a sophisticated understanding of its multifaceted origins and diagnostic complexities within modern healthcare systems. Prior research has shown that approximately 20-40% of individuals experience thoracic discomfort during their lifespan, highlighting the immense scale of this symptomatic burden on global health infrastructures and emergency services. While the incidence of obstructive coronary artery disease (CAD) has diminished, the frequency of patients presenting with these symptoms has paradoxically escalated over the previous decade, creating a diagnostic dilemma for practitioners. Clinicians must differentiate between cardiac, pulmonary, gastrointestinal, and psychiatric origins because symptomatology frequently overlaps across these distinct physiological systems, complicating the initial assessment and risk stratification process. Non-ischemic cardiac conditions like myocarditis, pericarditis, or aortic dissection further complicate the diagnostic landscape beyond traditional ischemic concerns, requiring precise identification to avoid catastrophic clinical outcomes. This absence of evidence motivated a systematic evaluation of how clinicians select appropriate diagnostic tools to manage this high-volume patient population effectively.

This review identifies optimal cardiac testing modalities for accurately diagnosing the underlying causes of thoracic discomfort in both ambulatory and emergency department (ED) settings. The investigation seeks to streamline the diagnostic process to reduce the multi-billion dollar annual burden on the United States healthcare infrastructure caused by extensive and often redundant testing protocols. Researchers evaluate the efficacy of various tools in distinguishing between life-threatening acute coronary syndrome (ACS), unstable angina, and stable angina presentations within diverse patient cohorts. The analysis focuses on providing clinicians with a robust framework to select the most appropriate test based on specific patient risk profiles and clinical environments. By synthesizing available evidence, the authors aim to improve the precision of cardiac assessments while simultaneously minimizing unnecessary procedural costs and resource utilization. The work addresses the inherent difficulty of relying solely on physical examinations or patient histories to confirm a diagnosis when symptoms overlap multiple organ systems.

The authors performed a comprehensive literature synthesis focusing on diagnostic protocols used in both emergency departments (ED) and primary care clinics to manage chest pain presentations. This review categorizes various investigative procedures according to their ability to detect obstructive coronary artery disease (CAD) versus non-ischemic pathologies such as valvopathies or heart failure. The researchers examined the diagnostic utility of history-taking and physical exams as baseline evaluative measures, noting their significant limitations in providing definitive etiologies for complex cases. Specific attention was given to the economic impact of different testing strategies within the American medical system, which currently incurs billions in annual costs for chest pain evaluations. The study design prioritized comparing modalities suitable for acute presentations against those better suited for stable, ambulatory patients requiring long-term diagnostic management. Analytical frameworks were applied to determine which specific tools provide the highest diagnostic yield for diverse etiologies, including gastrointestinal and musculoskeletal mimics.

Only 18% of patients presenting with thoracic symptoms receive a definitive diagnosis of cardiac origin, suggesting a high rate of non-cardiac etiologies in contemporary clinical practice. Despite the decreasing prevalence of obstructive coronary artery disease (CAD), the volume of patients seeking care for these symptoms has risen significantly over the last ten years, straining medical resources. The data indicates that symptomatology overlaps significantly between cardiac, musculoskeletal, and gastrointestinal systems, making physical exams alone insufficient for accurate diagnostic differentiation in most cases. Life-threatening conditions such as acute coronary syndrome (ACS) and aortic dissection require rapid identification through specific diagnostic pathways to ensure patient safety and optimal clinical outcomes. The review highlights that the current reliance on extensive testing contributes to billions of dollars in annual healthcare expenditures without always improving diagnostic clarity for the patient. Findings suggest that selecting the most appropriate modality depends heavily on whether the patient is in an emergency or ambulatory environment, influencing the required speed.

Effective management of chest pain requires a strategic approach to selecting diagnostic tools that balance clinical accuracy with systemic cost-efficiency across the healthcare continuum. Clinicians should prioritize identifying high-risk conditions like myocarditis or pericarditis while avoiding over-testing for non-cardiac issues that may present with similar symptoms. Future research should focus on refining the criteria for test selection to further reduce the economic strain on the medical system while maintaining high standards of care. The authors emphasize that a nuanced understanding of overlapping symptoms is vital for improving patient outcomes in both primary care and emergency settings. Implementing standardized protocols for cardiac testing modalities could enhance the speed of diagnosis for acute coronary syndrome (ACS) and other critical cardiovascular events. This synthesis provides a foundation for developing more targeted clinical guidelines that address the complexities of modern chest pain presentations across diverse healthcare settings and patient populations.